Ibuprofen Versus Acetaminophen vs Their Combination in the Relief of Musculoskeletal Pain in the Emergency Setting
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01827475 |
|
Recruitment Status :
Completed
First Posted : April 9, 2013
Results First Posted : December 31, 2014
Last Update Posted : December 31, 2014
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pain | Drug: Ibuprofen Drug: Acetaminophen Drug: Ibuprofen-acetaminophen combination | Phase 2 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 90 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Ibuprofen Versus Acetaminophen vs Their Combination in the Relief of Musculoskeletal Pain in the Emergency Setting |
| Study Start Date : | July 2010 |
| Actual Primary Completion Date : | July 2011 |
| Actual Study Completion Date : | July 2011 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Ibuprofen
Ibuprofen 800 mg
|
Drug: Ibuprofen
single dose
Other Name: motrin |
|
Active Comparator: Acetaminophen
Acetaminophen 1 gm
|
Drug: Acetaminophen
single dose
Other Name: tylenol |
|
Experimental: Ibuprofen-acetaminophen combination
Ibuprofen 800 mg plus acetaminophen 1 gm
|
Drug: Ibuprofen-acetaminophen combination
single dose
Other Names:
|
- Pain Severity [ Time Frame: 1 hour ]Pain score on 100 mm VAS from 0 (no pain) to 100 (worst pain)
- Need for Rescue Pain Relief [ Time Frame: 1 hour ]The need for additional analgesics
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult patients who presented to the emergency department with pain (a verbal numeric pain score greater than 0 on a scale of 0 to 10 from none to greatest) secondary to an acute musculoskeletal injury of less than 24 hours of duration when one of the study investigators was present were eligible for enrollment
Exclusion Criteria:
- Patients who had taken an opioid containing analgesic as well as those with a prior history of allergy or contraindications to ibuprofen or acetaminophen.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01827475
| Principal Investigator: | Adam J Singer, MD | Stony Brook University |
| Responsible Party: | Adam Singer, Professor and Vice Chair, Stony Brook University |
| ClinicalTrials.gov Identifier: | NCT01827475 |
| Other Study ID Numbers: |
IRBNet119536 |
| First Posted: | April 9, 2013 Key Record Dates |
| Results First Posted: | December 31, 2014 |
| Last Update Posted: | December 31, 2014 |
| Last Verified: | December 2014 |
|
musculoskeletal pain acetaminophen ibuprofen |
|
Musculoskeletal Pain Emergencies Disease Attributes Pathologic Processes Muscular Diseases Musculoskeletal Diseases Pain Neurologic Manifestations Acetaminophen Ibuprofen Analgesics, Non-Narcotic |
Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Antipyretics Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents Antirheumatic Agents Cyclooxygenase Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |

